Sitagliptin/metformin
| Combination of | |
|---|---|
| Sitagliptin | Dipeptidyl peptidase-4 inhibitor |
| Metformin | Biguanide |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin.
External links
 |
Wikimedia Commons has media related to Sitagliptin metformin. |
- JANUMET® XR (sitagliptin and metformin HCl extended-release) & JANUMET® (sitagliptin and metformin HCl)
- U.S. National Library of Medicine: Drug Information Portal – Janumet
- Janumet Uses, Dosage & Side Effects - Drugs.com
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.